Search

Your search keyword '"Sheu, Wayne H.-H."' showing total 686 results

Search Constraints

Start Over You searched for: "Sheu, Wayne H.-H." Remove constraint "Sheu, Wayne H.-H."
686 results on '"Sheu, Wayne H.-H."'

Search Results

2. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

3. Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing

4. Rare coding variants in RCN3 are associated with blood pressure

5. Gene Sequencing Identifies Perturbation in Nitric Oxide Signaling as a Nonlipid Molecular Subtype of Coronary Artery Disease

7. Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia

8. Genetic determinants of telomere length from 109,122 ancestrally diverse whole-genome sequences in TOPMed

9. Whole genome sequence analyses of eGFR in 23,732 people representing multiple ancestries in the NHLBI trans-omics for precision medicine (TOPMed) consortium

10. Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.

11. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

13. Device-supported automated basal insulin titration in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

14. Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

15. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation

16. Multiethnic Genome-wide Association Study of Diabetic Retinopathy using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control

17. Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries

18. A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes

19. Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease

20. Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial

21. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease

22. Trans-ethnic fine-mapping of genetic loci for body mass index in the diverse ancestral populations of the Population Architecture using Genomics and Epidemiology (PAGE) Study reveals evidence for multiple signals at established loci

23. Genome-Wide Association Study Meta-Analysis of Long-Term Average Blood Pressure in East Asians

25. Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci

27. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

28. The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

30. Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci

31. Genetics of Coronary Artery Disease in Taiwan: A Cardiometabochip Study by the Taichi Consortium.

33. Identification of type 2 diabetes loci in 433,540 East Asian individuals

35. Multiple Nonglycemic Genomic Loci Are Newly Associated With Blood Level of Glycated Hemoglobin in East Asians

36. The Chromosome 9p21 Variant Not Predicting Long-Term Cardiovascular Mortality in Chinese with Established Coronary Artery Disease: An Eleven-Year Follow-Up Study

37. Rare variants in long non-coding RNAs are associated with blood lipid levels in the TOPMed whole-genome sequencing study

38. Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

40. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes

41. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

44. Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications

45. Associations of autozygosity with a broad range of human phenotypes

49. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide

50. Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

Catalog

Books, media, physical & digital resources